4,575
Views
34
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials

, , , , , , , , , , & show all
Pages 36-43 | Received 20 Dec 2018, Accepted 25 Jan 2019, Published online: 21 Mar 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.